Persistence while on labeled maintenance dose among advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or adalimumab

This study compared persistence while on labeled maintenance dose among ADT-experienced patients with UC initiated on ustekinumab or adalimumab.

Source: Gastroenterology - January 25, 2024 Category: Gastroenterology Authors: Porpong Boonmak, Sumesh Kachroo, Maryia Zhdanava, Sabree Burbage, Aditi Shah, Jill Korsiak, Patrick Lefebvre, Caroline Kerner, Dominic Pilon Source Type: research